Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
sitaxsentan
|
| gptkbp:ATCCode |
C02KX03
|
| gptkbp:CASNumber |
212779-48-1
|
| gptkbp:chemicalFormula |
C20H15N3O4S
|
| https://www.w3.org/2000/01/rdf-schema#label |
Thelin (sitaxsentan)
|
| gptkbp:indication |
pulmonary arterial hypertension
|
| gptkbp:legalStatus |
withdrawn
|
| gptkbp:manufacturer |
gptkb:Encysive_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
endothelin receptor antagonist
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:anemia
edema headache nasal congestion liver injury |
| gptkbp:status |
withdrawn
|
| gptkbp:synonym |
sitaxsentan sodium
|
| gptkbp:withdrawn |
true
liver toxicity |
| gptkbp:bfsParent |
gptkb:Texas_Biotechnology
|
| gptkbp:bfsLayer |
8
|